Urodynamix Technologies Ltd.

	Sign up to receive news releases and updates by email:

	Subscribe
	Unsubscribe

2008
November 13	Urodynamix and Pfizer Inc. Launch Promotional Program in Boston
November 6	Urodynamix Technologies Ltd. Closes $2.5 Million Private Placement
November 3	Urodynamix Appoints Chief Financial Officer
October 22	Urodynamix and Laborie Medical Expand Distribution Rights
October 21	Urodynamix and Medical Measurement Systems Announce Worldwide Agreement to Expand Distribution for Bladder Product
October 15	BC Advantage Funds Increases Stake in Urodynamix Technologies Ltd.
October 9	Urodynamix Announces Publication of Two Articles in Canadian Journal of Urology
October 6	Urodynamix and Timm Medical Sign Development and Distribution Agreement
September 23	Urodynamix and Pfizer Inc. Collaborate on Urologist Program
September 17	Urodynamix Submits 510(k) Filing to FDA for Second Generation Bladder Monitor
September 2	Laborie Receives CE Mark and Canadian Medical Device Licence for Tetra Bladder Monitor System
August 25	Urodynamix Awarded NRC-IRAP Support for New Prostate Cancer Detection Technology
June 10	Urodynamix Appoints Vice President of Business Development
June 4	Urodynamix Launches Tetra-NIRS Marketing Trials
May 20	Urodynamix and Laborie Launch Tetra(TM) Bladder Monitor System
April 2	Urodynamix Announces First Commercial Product Shipment
March 31	Urodynamix Technologies Receives ISO 13485 Certification
March 25	Urodynamix Announces Second Collaboration for Development of NIRS Prostate Treatment Device
March 11	Urodynamix Announces Grant of Stock Options
March 10	Laborie Medical Technologies Receives FDA 510(k) Clearance for Tetra™ Bladder Monitor System
March 3	Urodynamix Signs Collaborative Agreement for NIRS Prostate Treatment Device
February 26	Urodynamix Develops Next Generation NIRS Prostate Monitoring System
February 6	Urodynamix NIRS IAP Data Presented at Society of Critical Care Medicine Annual Meeting
January 4	Urodynamix Announces Grant of Stock Options
2007
December 19	Urodynamix Technologies Announces Positive Data from LUTS Pivotal Trial
December 17	Laborie Medical Technologies Submits 510(k) Application to FDA for Tetra(TM) Bladder Monitor System
October 9	Urodynamix Announces New Device to Help Diagnose Prostate Cancer
October 4	Urodynamix Appoints David Goodkin, MD to Board of Directors
September 18	Urodynamix Announces Grant of Stock Options
September 13	Urodynamix Commences Enrollment in Third IAP Clinical Trial
August 31	Urodynamix and Laborie to Exhibit at SIU 2007
August 20	Urodynamix and Laborie to Exhibit at ICS 2007
August 14	Urodynamix Warrant Exercise Raises $900,000
July 26	Funds Managed by Lions Capital Acquire Additional Interest in Urodynamix Technologies
July 25	Urodynamix Raises $1.9 Million from Exercise of Warrants
June 8	Urodynamix Announces Grant of Stock Options
June 7	Urodynamix Files Patent Applications
June 6	Urodynamix Reports 2007 Annual Meeting Results
May 23	Urodynamix Cancels Proposed Share Consolidation
May 18	Urodynamix and Laborie Medical Technologies to Unveil URO-NIRS Bladder Monitor at the 2007 American Urological Association Annual Meeting
May 17	Urodynamix and Laborie Medical Technologies Announce Worldwide Distribution Agreement
May 16	Urodynamix Announces NIRS Data to be Presented at 2007 American Urological Association Annual Meeting
May 8	Urodynamix Data to be Presented at Leading Trauma Conference
May 4	Urodynamix Announces Annual and Special Shareholder Meeting Agenda
April 12	Urodynamix Expands NIRS Intra-Abdominal Pressure Study
March 8	Urodynamix Reports Positive Results from Second Female UI Study
February 26	Urodynamix Announces Positive Results from NIRS Prostate Study 2
February 21	Urodynamix Discovers NIRS Application for Diagnosis of Erectile Dysfunction
February 20	Urodynamix Forms Medical Advisory Board
February 19	Urodynamix Appoints Corporate Secretary
January 17	Urodynamix Discovers New NIRS Application
2006
2005